Rebismart 2.0

· Merck KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rebismart 2.0, covering 2016-04-25 to 2016-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)